The spatial folding of chromosomes inside the nucleus has regulatory effects on gene expression, yet the impact of genome reshuffling on this organization remains unclear. Here, we take advantage of chromosome conformation capture in combination with single-nucleotide polymorphism (SNP) genotyping and analysis of crossover events to study how the higher-order chromatin organization and recombination landscapes are affected by chromosomal fusions in the mammalian germ line.

 

We demonstrate that chromosomal fusions alter the nuclear architecture during meiosis, including an increased rate of heterologous interactions in primary spermatocytes, and alterations in both chromosome synapsis and axis length.

 

These disturbances in topology were associated with changes in genomic landscapes of recombination, resulting in detectable genomic footprints. Overall, we show that chromosomal fusions impact the dynamic genome topology of germ cells in two ways: (i) altering chromosomal nuclear occupancy and synapsis, and (ii) reshaping landscapes of recombination.

 

Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of HNSCC with or without HPV infection

Head and neck squamous cell carcinoma (HNSCC) are the sixth most common cancer type in the world. Human papillomavirus (HPV) infection is an emerging risk factor for HNSCC. Immune infiltration of HNSCC is linked to therapeutic results. This article aimed to decide whether variations in HPV status affect immune infiltration, molecular mechanism, and how these results vary in HNSCC patients.

 

We investigated the tumor-infiltrating immune cells (TIICs) and immune-related gene differences between HPV (+) and HPV (-) HNSCC. The gene expression quantification data of HNSCC and their clinical information were download from the TCGA database. Immune-related genes have been linked to the ImmPort platform.

 

After analyzed of 22 TIICs in the HNSCC tumor environment by CIBERSORT and further assessment, lower memory B cell and higher T cell regulatory were connected with better HPV (-) HNSCC outcome, higher activated memory CD4 T cell, higher T cell regulatory, and lower activated NK cell were linked with better HPV (+) result.

 

We finally got five forms of immune genes (CAMP, EDNRB, NTS, CXCL9, LHB) associated with HNSCC progression. Higher expressions of CAMP, EDNRB, and NTS were associated with increased overall survival in HPV (-) patients. Higher expression of CXCL9 and lower expression of LHB contributed to increased overall survival of HPV (+) patients.

 

There tend to be discrepancies in the cell structure of TIICs and immune-related genes in HPV (-) and HPV (+) HNSCC. These variances are typically too crucial for the therapeutic outcome of the patient and the development of the tumor. In specific, our sample established these candidate immune cells and immune-related genes as candidate reservoirs for further researches.

Multi-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage

The evolutionary pressure of endemic malaria and other erythrocytic pathogens has shaped variation in genes encoding erythrocyte structural and functional proteins, influencing responses to hemolytic stress during transfusion and disease.

 

We sought to identify such genetic variants in blood donors by conducting a genome-wide association study (GWAS) of 12,353 volunteer donors, including 1,483 African Americans, 1,477 Asians, and 960 Hispanics, whose stored erythrocytes were characterized by quantitative assays of in vitro osmotic, oxidative, and cold-storage hemolysis.

GWAS revealed 27 significant loci (p<5×10-8), many in candidate genes known to modulate erythrocyte structure, metabolism, and ion channels, including SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/Band 3. GWAS of oxidative hemolysis identified variants in antioxidant enzymes including GLRX, GPX4, G6PD, and a novel golgi-transport protein SEC14L4.

 

Genome wide significant loci were also tested for association with the severity of steady state (baseline) in vivo hemolytic anemia in patients with sickle cell disease, with confirmation of identified SNPs in HBA2, G6PD, PIEZO1, AQP1 and SEC14L4. Many of the identified variants, such as those in G6PD, have previously been shown to impair erythrocyte recovery after transfusion, associate with anemia, or cause rare Mendelian human hemolytic diseases.

Candidate SNPs in these genes, especially in polygenic combinations, may affect RBC recovery after transfusion and modulate disease severity in hemolytic diseases, such as sickle cell disease and malaria.

Incorporating Genomic and Genetic Testing into the Treatment of Metastatic Luminal Breast Cancer

Background: Treatment of patients with luminal metastatic breast cancer (MBC) has become even more complex over the last few years as molecular profiling has begun to alter disease management. It is well accepted that MBC is not curable but is treatable. Today we are able to prolong progression-free survival and partly overall survival with targeted and more individual treatment strategies adjusted according to the molecular subtype.

Summary: Genetic and genomic testing has become therapeutically relevant in luminal MBC and is therefore an integral component within the treatment spectrum. By now, germline testing of BRCABRCAPIK3CA mutations are inevitable elements in disease management and the current state of the art in luminal MBC patients.

Furthermore, testing of ESR1 resistance mutation, ERBB2 mutation, microsatellite instability, and neurotrophic tyrosine receptor kinase (NTRK) gene fusion (mainly in secretory breast cancer) has recently gained increasing attention. However, based on the expanding role of personalized medicine, clinicians are now faced with substantial new challenges and possibly unsuspected possibilities. The following review summarizes current developments in genetic and genomic testing in luminal MBC.

Key messages: In luminal MBC genomics have become an integral component within the spectrum of oncological treatment establishing novel therapeutic facilities. Further developments in treatment personalization adjusted according to the molecular subtype should become increasingly important in order to enhance the progress of de-escalation of chemotherapy in luminal MBC. However, based on the expanding role of personalized medicine, clinicians are now faced with substantial new challenges and possibly unsuspected possibilities.

 

HIV-1 p24 ELISA Kit
Z7040001	Biochain	1 kit	EUR 974.4
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol.

HIV-1 p24
E5-00024	EnoGene	1mg	EUR 1152

HIV-1 p24
E62H002	EnoGene	100ug	EUR 458.4

HIV Type 1 p24 Antigen ELISA (96 Determinations)
0801111	Zeptometrix	96T	EUR 657.79
Description: Please contact Gentaur in order to receive the datasheet of the product.

HIV Type 1 p24 Antigen ELISA (96 Determinations)
801111	Zeptometrix	96 Determinations	EUR 591

HIV Type 1 p24 Antigen ELISA 2.0 (96 Determinations)
0801002	Cusabio	96T	EUR 657.79
Description: Please contact Gentaur in order to receive the datasheet of the product.

HIV Type 1 p24 Antigen ELISA 2.0 (96 Determinations)
801002	Zeptometrix	96 Determinations	EUR 574

HIV type 1 P24
DAG1520	Creative Diagnostics	100 µg	EUR 972

HIV-1 p24 Antibody
7313-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains.

HIV-1 p24 Antibody
7313-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains.

Recombinant HIV-1 p24
7-07603	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 p24
7-07604	CHI Scientific	500µg	Ask for price

Recombinant HIV-1 p24
7-07605	CHI Scientific	1000µg	Ask for price

HIV-1 Gag p24
05-005	Sceti	50 ug	EUR 434.4
Description: The HIV-1 Gag p24 is available in Europe and for worldwide shipping via Gentaur.

HIV-1 Gag p24
05-006	Sceti	250 ug	EUR 1154.4
Description: The HIV-1 Gag p24 is available in Europe and for worldwide shipping via Gentaur.

HIV-1, p24 Protein
abx069857-1mg	Abbexa	1 mg	EUR 1888.8

HIV-1 p24 Protein
abx169032-1mg	Abbexa	1 mg	EUR 661.2

HIV-1 p24 Antibody
20-abx137062	Abbexa	EUR 427.20 EUR 627.60	0.5 mg 1 mg

HIV-1 p24 Antibody
abx021869-1mg	Abbexa	1 mg	EUR 794.4

HIV-1 p24 Antibody
abx021870-1mg	Abbexa	1 mg	EUR 760.8

HIV-1 p24 Antibody
abx021871-1mg	Abbexa	1 mg	EUR 794.4

HIV-1 p24 Antibody
abx021872-1mg	Abbexa	1 mg	EUR 794.4

HIV-1 p24 Antibody
abx021873-1mg	Abbexa	1 mg	EUR 794.4

HIV-1 p24 Antibody
abx021882-1mg	Abbexa	1 mg	EUR 1178.4

HIV-1 p24 Antibody
abx021883-1mg	Abbexa	1 mg	EUR 1220.4

HIV-1 p24 Antibody
abx021886-1mg	Abbexa	1 mg	EUR 1220.4

HIV-1 p24 Antibody
abx021887-1mg	Abbexa	1 mg	EUR 1220.4

HIV-1 p24 Antibody
abx021888-1mg	Abbexa	1 mg	EUR 1220.4

HIV-1 p24 Antibody
abx023027-1ml	Abbexa	1 ml	EUR 693.6

HIV 1 p24 Protein
abx060589-1mg	Abbexa	1 mg	EUR 1545.6

HIV-1 p24 Protein
abx061424-05mg	Abbexa	0.5 mg	EUR 886.8

HIV-1 p24 Antibody
abx023925-1mg	Abbexa	1 mg	EUR 828

HIV-1 p24 Antibody
abx023926-1mg	Abbexa	1 mg	EUR 828

HIV-1 p24 Protein
20-abx261886	Abbexa	EUR 5388.00 EUR 393.60 EUR 276.00	1 mg 20 ug 5 ug

p24-HIV(p24/661) Antibody
BNCA0661-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against p24-HIV(p24/661), APC conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNCAP0661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNCAP0661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC610661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF660R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC610661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF660R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNCR0661-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against p24-HIV(p24/661), RPE conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNUB0661-100	Biotium	100uL	EUR 250.8
Description: Primary antibody against p24-HIV(p24/661), Concentration: 0.2mg/mL

p24-HIV(p24/661) Antibody
BNUB0661-500	Biotium	500uL	EUR 549.6
Description: Primary antibody against p24-HIV(p24/661), Concentration: 0.2mg/mL

p24-HIV(p24/661) Antibody
BNC430661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF543 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC430661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF543 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC400661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF640R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC400661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF640R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC880661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF488A conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC880661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF488A conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC810661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF680R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC810661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF680R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNCH0661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNCH0661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNCP0661-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against p24-HIV(p24/661), PerCP conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNUM0661-50	Biotium	50uL	EUR 474
Description: Primary antibody against p24-HIV(p24/661), 1mg/mL

p24-HIV(p24/661) Antibody
BNC050661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF405M conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC050661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF405M conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC680661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF568 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC680661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF568 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC700661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF770 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC700661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF770 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC800661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF680 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC800661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF680 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNCB0661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), Biotin conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNCB0661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), Biotin conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC940661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF594 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC940661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF594 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC550661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF555 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC550661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF555 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC470661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF647 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC470661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF647 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC040661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF405S conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC040661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF405S conjugate, Concentration: 0.1mg/mL

HIV p24 Antibody
abx021867-1mg	Abbexa	1 mg	EUR 1612.8

HIV p24 Antibody
abx021868-1mg	Abbexa	1 mg	EUR 1612.8

Human(HIV-P24)
QY-E05679	Qayee Biotechnology	96T	EUR 433.2

HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations)
801200	Zeptometrix	5 X 96 Determinations	EUR 2330

HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations)
0801200	Zeptometrix	5 X 96T	EUR 2543.52
Description: Please contact Gentaur in order to receive the datasheet of the product.

Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed
ELISA-1	Alpha Diagnostics	1	EUR 242.4

HIV type 1 P24 [His]
DAG2375	Creative Diagnostics	100 µg	EUR 868.8

HIV type 1 P24 [His]
DAG2377	Creative Diagnostics	100 µg	EUR 868.8

HIV type 1 p24 [FITC]
DAGH004	Creative Diagnostics	50 Tests	EUR 1112.4

HIV type 1 P24 [GST]
DAG1516	Creative Diagnostics	100 µg	EUR 774

HIV type 1 P24 [His]
DAG1518	Creative Diagnostics	100 µg	EUR 774

HIV type 1 P24 [Biotin]
DAG1519	Creative Diagnostics	100 µg	EUR 972

HIV type 1 P24 [His]
DAG1799	Creative Diagnostics	50 ug	EUR 2017.2

HIV-1 p24 Recombinant Protein
53-341	ProSci	0.01 mg	EUR 789.9
Description: HIV-1 p24 Recombinant Protein

Recombinant HIV-1 p24 Core
7-07597	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 p24 Core
7-07598	CHI Scientific	500µg	Ask for price

Recombinant HIV-1 p24 Core
7-07599	CHI Scientific	1000µg	Ask for price

Recombinant HIV-1 p24 , 24kDa
7-07621	CHI Scientific	2µg	Ask for price

Recombinant HIV-1 p24 , 24kDa
7-07622	CHI Scientific	10µg	Ask for price

Recombinant HIV-1 p24 , 24kDa
7-07623	CHI Scientific	100µg	Ask for price

HIV 1 / 2 p24 Antibody
abx021866-1mg	Abbexa	1 mg	EUR 1212

HIV-1 p24 Antibody (FITC)
abx021884-100ug	Abbexa	100 ug	EUR 886.8

HIV 1 / 2 p24 Antibody
abx021890-1mg	Abbexa	1 mg	EUR 1212

HIV-1 p24 Antibody (FITC)
abx023026-1ml	Abbexa	1 ml	EUR 678

HIV-1 p24 Antibody (Biotin)
abx023028-1ml	Abbexa	1 ml	EUR 794.4

HIV-1 p24 Antibody (HRP)
abx023029-1ml	Abbexa	1 ml	EUR 886.8

HIV-1 p24 Core Protein
20-abx260141	Abbexa	EUR 1062.00 EUR 410.40 EUR 1646.40	0.5 mg 100 ug 1 mg

Polyclonal HIV-1 p24 Antibody
APR11116G	Leading Biology	0.1 mg	EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HIV-1 p24 . This antibody is tested and proven to work in the following applications:

HIV-1 p24, His tag
E410A26-20	EnoGene	20μg	EUR 520.8

HIV-1 p24 Antibody [8G9]
PM-6335-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9]
PM-6335-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4]
PM-6585-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4]
PM-6585-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

Anti-HIV-1 p24 Antibody
STJ60071	St John's Laboratory	100 µg	EUR 508.8

Anti-HIV-1 p24 Antibody
STJ60072	St John's Laboratory	100 µg	EUR 508.8

HIV Type-1 p24 Antibody
V2344-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

HIV Type-1 p24 Antibody
V2344-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

HIV Type-1 p24 Antibody
V2344CF488-100T	NSJ Bioreagents	100 Tests	EUR 499
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

HIV Type-1 p24 Antibody
V2344SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

Human HIV(1+2 antibodies plus p24 antigen (4th Generation) ELISA Kit
EH4101	FN Test	96T	EUR 571.5
Description: Method of detection: Qualitative ;Reacts with: Homo sapiens;Sensitivity: Qualitative

HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations)
0801008	Zeptometrix	5 X 96T	EUR 2543.52
Description: Please contact Gentaur in order to receive the datasheet of the product.

HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations)
801008	Zeptometrix	5 X 96 Determinations	EUR 2386

HIV-1 p24 Immune Complex Dissociation Kit
Z7040009	Biochain	1 kit	EUR 207.6
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol.

Anti-HIV p24 antibody
10-2842	Fitzgerald	1 mg	EUR 360
Description: Anti-HIV p24 Ag monoclonal antibody

Anti-HIV p24 antibody
10-2843	Fitzgerald	1 mg	EUR 360
Description: Anti-HIV p24 Ag monoclonal antibody

Anti-HIV p24 antibody
10-2844	Fitzgerald	1 mg	EUR 360
Description: Anti-HIV p24 Ag monoclonal antibody

Anti-HIV p24 antibody
10-2845	Fitzgerald	1 mg	EUR 360
Description: Anti-HIV p24 Ag monoclonal antibody

QuickTiter HIV Lentivirus Quantitation Kit (p24 ELISA)
VPK-108-H	Cell Biolabs	96 assays	EUR 866.4
Description: Quantitation of the HIV-1 p24 core protein of a lentiviral vector is an efficient, well-published method for determining lentivirus physical titer. The QuickTiter Lentivirus Quantitation Kits provide a convenient method of p24 antigen quantitation.

QuickTiter HIV Lentivirus Quantitation Kit (p24 ELISA)
VPK-108-H-5	Cell Biolabs	5 x 96 assays	EUR 3560.4
Description: Quantitation of the HIV-1 p24 core protein of a lentiviral vector is an efficient, well-published method for determining lentivirus physical titer. The QuickTiter Lentivirus Quantitation Kits provide a convenient method of p24 antigen quantitation.

HIV type 1 P24 (HXBc2) [His]
DAG2376	Creative Diagnostics	100 µg	EUR 868.8

HIV type 1 P24 (p24HXBc2) [His]
DAG2378	Creative Diagnostics	100 µg	EUR 1095.6

HIV type 1 P24 (CN54) [His]
DAG2380	Creative Diagnostics	100 µg	EUR 1095.6

Recombinant HIV-1 p24 Core, Sf9
7-07600	CHI Scientific	2µg	Ask for price

Recombinant HIV-1 p24 Core, Sf9
7-07601	CHI Scientific	10µg	Ask for price

Recombinant HIV-1 p24 Core, Sf9
7-07602	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 p24 His Tag
7-07606	CHI Scientific	5µg	Ask for price

Recombinant HIV-1 p24 His Tag
7-07607	CHI Scientific	20µg	Ask for price

Recombinant HIV-1 p24 His Tag
7-07608	CHI Scientific	1mg	Ask for price

Recombinant HIV-1 p24, Biotin Labeled
7-07612	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 p24, Biotin Labeled
7-07613	CHI Scientific	500µg	Ask for price

Recombinant HIV-1 p24, Biotin Labeled
7-07614	CHI Scientific	1000µg	Ask for price

Recombinant HIV-1 gag p17, p24
7-07675	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 gag p17, p24
7-07676	CHI Scientific	500µg	Ask for price

Recombinant HIV-1 gag p17, p24
7-07677	CHI Scientific	1000µg	Ask for price

Mouse antibody for HIV-1 p24
1941	Virostat	100 ug	EUR 399.3
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1946	Virostat	100 ug	EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1947	Virostat	100 ug	EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1948	Virostat	100 ug	EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1949	Virostat	100 ug	EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

HIV-1 gag p24 IIIB Protein
abx060586-05mg	Abbexa	0.5 mg	EUR 1128

HIV-1 p24 Core, Sf9 Protein
20-abx260012	Abbexa	EUR 2815.20 EUR 493.20 EUR 276.00	100 ug 10 ug 2 µg

HIV-1 gag p17, p24 Protein
20-abx260277	Abbexa	EUR 1062.00 EUR 410.40 EUR 1930.80	0.5 mg 100 ug 1 mg

HIV-1 p24, Biotin Labeled Protein
20-abx260358	Abbexa	EUR 1496.40 EUR 560.40 EUR 2364.00	0.5 mg 100 ug 1 mg

HIV-1 p24, 24 kDa Protein
20-abx263118	Abbexa	EUR 1562.40 EUR 393.60 EUR 276.00	100 ug 10 ug 2 µg

Polyclonal HIV-1 p24 Antibody [7F4]
APR11117G	Leading Biology	0.1 mg	EUR 790.8
Description: A polyclonal antibody raised in Mouse that recognizes and binds to Human HIV-1 p24 [7F4] . This antibody is tested and proven to work in the following applications:

HIV-1 p24 Antibody [8G9] (biotin)
PM-6335-biotin-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9] (biotin)
PM-6335-biotin-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9] (HRP)
PM-6335-HRP-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9] (HRP)
PM-6335-HRP-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (biotin)
PM-6585-biotin-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (biotin)
PM-6585-biotin-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (HRP)
PM-6585-HRP-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (HRP)
PM-6585-HRP-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

Recombinant HIV-1 p24 Protein [His]
VAng-0527Lsx-inquire	Creative Biolabs	inquire	Ask for price
Description: HIV type 1 P24 Antigen, recombinant protein from insect cell expression system.

Recombinant HIV-1 P24 Protein (Gorillas)
VAng-Lsx0245-1mg	Creative Biolabs	1 mg	EUR 3058.8
Description: HIV type 1 P24 (Antigen), recombinant protein from E. coli.

Monoclonal Mouse Anti-Hiv（P24）
C010105-10mg	Unibiotest	10mg	EUR 1641.6

Monoclonal Mouse Anti-Hiv（P24）
C010105-1mg	Unibiotest	1mg	EUR 322.8

Recombinant HIV-I p24 gag
7-07618	CHI Scientific	100µg	Ask for price

Recombinant HIV-I p24 gag
7-07619	CHI Scientific	500µg	Ask for price

Recombinant HIV-I p24 gag
7-07620	CHI Scientific	1000µg	Ask for price

anti-HIV p24 Monoclonal antibody
012-A-01mg	Virogen	0,1 mg	EUR 321
Description: anti-HIV-1 p24 IgG1 (monoclonal) Produced against a recombinant protein.

anti-HIV p24 Monoclonal antibody
012-A-1000ug	Virogen	1000 ug	EUR 1539
Description: anti-HIV-1 p24 IgG1 (monoclonal) Produced against a recombinant protein.

HIV-I p24 gag Protein
20-abx260279	Abbexa	EUR 1062.00 EUR 410.40 EUR 1930.80	0.5 mg 100 ug 1 mg

Anti-HIV p24 protein antibody
STJ16100518	St John's Laboratory	100 µg	EUR 487.2

Anti-HIV/p24 monoclonal Antibody
A1020-100	Biovision	each	EUR 444

Goat Anti-HIV-1 p24 Polyclonal Antibody
DPAB0249	Creative Diagnostics	1 ml	EUR 781.2

Goat Anti-HIV-1 p24 Polyclonal Antibody
DPAB0250	Creative Diagnostics	1 ml	EUR 826.8

Goat Anti-HIV-1 p24 Polyclonal Antibody
DPAB0251	Creative Diagnostics	1 ml	EUR 1146

HIV-1 gag Protein p24 (137-154)
5-01316	CHI Scientific	4 x 1mg	Ask for price

HIV-1 gag Protein p24 (194-210)
5-01317	CHI Scientific	4 x 1mg	Ask for price

Recombinant HIV-1 p24 gag, His Tag
7-07609	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 p24 gag, His Tag
7-07610	CHI Scientific	500µg	Ask for price

Recombinant HIV-1 p24 gag, His Tag
7-07611	CHI Scientific	1000µg	Ask for price

Recombinant HIV-1 p24, Horseradish Peroxidase Labeled
7-07615	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 p24, Horseradish Peroxidase Labeled
7-07616	CHI Scientific	500µg	Ask for price

Recombinant HIV-1 p24, Horseradish Peroxidase Labeled
7-07617	CHI Scientific	1000µg	Ask for price

Recombinant HIV-1 gag p17, p24, gp120
7-07678	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 gag p17, p24, gp120
7-07679	CHI Scientific	500µg	Ask for price

Recombinant HIV-1 gag p17, p24, gp120
7-07680	CHI Scientific	1000µg	Ask for price

Anti-Capsid protein p24 (HIV-1) Purified
11-327-C025	ExBio	0.025 mg	EUR 135.6

Anti-Capsid protein p24 (HIV-1) Purified
11-327-C100	ExBio	0.1 mg	EUR 223.2

Mouse Monoclonal Anti- HIV-1 p24 IgG
AB-15210	Alpha Diagnostics	100 ug	EUR 416.4

HIV-1 gag p17, p24, gp120 Protein
20-abx260274	Abbexa	EUR 1062.00 EUR 410.40 EUR 1930.80	0.5 mg 100 ug 1 mg

HIV-1 p24, Horseradish Peroxidase Labeled Protein
20-abx260359	Abbexa	EUR 1496.40 EUR 560.40 EUR 2364.00	0.5 mg 100 ug 1 mg

HIV-1 gag Protein p24 (194-210)
H-2986.0500	Bachem	0.5mg	EUR 327.6
Description: Sum Formula: C73H126N20O23S; CAS# [141281-67-6]

HIV-1 gag Protein p24 (194-210)
H-2986.1000	Bachem	1.0mg	EUR 559.2
Description: Sum Formula: C73H126N20O23S; CAS# [141281-67-6]

HIV-1 gag Protein p24 (137-154)
H-3006.0500	Bachem	0.5mg	EUR 327.6
Description: Sum Formula: C92H158N26O26S; CAS# [198636-98-5]

HIV-1 gag Protein p24 (137-154)
H-3006.1000	Bachem	1.0mg	EUR 559.2
Description: Sum Formula: C92H158N26O26S; CAS# [198636-98-5]